• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨坏死与骨髓水肿综合征中的凝血异常

Coagulation abnormalities in osteonecrosis and bone marrow edema syndrome.

作者信息

Orth Patrick, Anagnostakos Konstantinos

机构信息

Department of Orthopaedic Surgery, Saarland University Medical Center, Homburg, Saar, Germany.

出版信息

Orthopedics. 2013 Apr;36(4):290-300. doi: 10.3928/01477447-20130327-08.

DOI:10.3928/01477447-20130327-08
PMID:23590772
Abstract

The aim of this review was to provide information about the variety of thrombophilic and hypofibrinolytic markers that are possible risk factors for the development of osteonecrosis and bone marrow edema syndrome. A total of 48 parameters were identified in 45 studies that included 2163 patients. The most frequently reported laboratory findings included altered serum concentrations of lipoproteins, decreased concentration and function of fibrinolytic agents, increased levels of thrombophilic markers, and several single nucleotide polymorphisms. Despite inhomogeneities in reported parameters, results, patients' collectives, and treatment strategies, these data suggest that coagulation abnormalities may play an important role in the emergence of osteonecrosis and bone marrow edema syndrome.

摘要

本综述的目的是提供有关多种血栓形成倾向和低纤溶标记物的信息,这些标记物可能是骨坏死和骨髓水肿综合征发生的危险因素。在45项研究中总共确定了48个参数,这些研究纳入了2163例患者。最常报告的实验室检查结果包括血清脂蛋白浓度改变、纤溶因子浓度和功能降低、血栓形成倾向标记物水平升高以及几种单核苷酸多态性。尽管所报告的参数、结果、患者群体和治疗策略存在异质性,但这些数据表明凝血异常可能在骨坏死和骨髓水肿综合征的发生中起重要作用。

相似文献

1
Coagulation abnormalities in osteonecrosis and bone marrow edema syndrome.骨坏死与骨髓水肿综合征中的凝血异常
Orthopedics. 2013 Apr;36(4):290-300. doi: 10.3928/01477447-20130327-08.
2
Relationship between bone marrow edema and development of symptoms in patients with osteonecrosis of the femoral head.股骨头坏死患者骨髓水肿与症状发展之间的关系
AJR Am J Roentgenol. 2006 Jun;186(6):1761-70. doi: 10.2214/AJR.05.0086.
3
Bone marrow oedema and aseptic osteonecrosis in children and adolescents with acute lymphoblastic leukaemia or non-Hodgkin-lymphoma treated with hyperbaric-oxygen-therapy (HBO): an approach to cure? -- BME/AON and hyperbaric oxygen therapy as a treatment modality.接受高压氧治疗(HBO)的急性淋巴细胞白血病或非霍奇金淋巴瘤儿童及青少年的骨髓水肿和无菌性骨坏死:一种治愈方法?——骨髓水肿/无菌性骨坏死与高压氧治疗作为一种治疗方式
Klin Padiatr. 2004 Nov-Dec;216(6):370-8. doi: 10.1055/s-2004-832341.
4
[The transitory bone marrow edema syndrome of the hip].[髋关节短暂性骨髓水肿综合征]
Z Orthop Ihre Grenzgeb. 2002 May-Jun;140(3):286-96. doi: 10.1055/s-2002-32466.
5
Role of serum lipoprotein at the site of iloprost therapy in the treatment of painful bone marrow edema.血清脂蛋白在伊洛前列素治疗疼痛性骨髓水肿部位的作用。
Orthopedics. 2013 Oct 1;36(10):e1283-9. doi: 10.3928/01477447-20130920-21.
6
Procoagulants and osteonecrosis.促凝血剂与骨坏死
J Rheumatol. 2003 Apr;30(4):783-91.
7
Correlation between bone marrow edema and collapse of the femoral head in steroid-induced osteonecrosis.类固醇诱导的股骨头坏死中骨髓水肿与股骨头塌陷的相关性
AJR Am J Roentgenol. 2000 Mar;174(3):735-43. doi: 10.2214/ajr.174.3.1740735.
8
Fatty marrow conversion of the proximal femoral metaphysis in transient bone marrow edema syndrome.短暂性骨髓水肿综合征中股骨近端干骺端的脂肪骨髓转化
Arch Orthop Trauma Surg. 2005 Jul;125(6):390-5. doi: 10.1007/s00402-005-0824-4. Epub 2005 May 13.
9
A preliminary pilot study of treatment of thrombophilia and hypofibrinolysis and amelioration of the pain of osteonecrosis of the jaws.一项关于治疗血栓形成倾向和纤维蛋白溶解功能减退以及改善颌骨骨坏死疼痛的初步试点研究。
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998 Jan;85(1):64-73. doi: 10.1016/s1079-2104(98)90400-0.
10
Osteonecrosis, transient osteoporosis, and transient bone marrow edema: current concepts.骨坏死、暂时性骨质疏松症和暂时性骨髓水肿:当前概念
Radiol Clin North Am. 1996 Mar;34(2):273-91, x.

引用本文的文献

1
[Pharmacological therapy for subchondral pathologies of the knee joint].[膝关节软骨下病变的药物治疗]
Orthopadie (Heidelb). 2025 May;54(5):354-360. doi: 10.1007/s00132-025-04625-8. Epub 2025 Mar 19.
2
Thrombophilia, hypofibrinolysis and osteonecrosis.血栓形成倾向、纤维蛋白溶解功能减退与骨坏死。
Orthopadie (Heidelb). 2025 May;54(5):376-385. doi: 10.1007/s00132-024-04606-3. Epub 2025 Feb 19.
3
A nosographic and etiopathogenetic framework for subchondral bone marrow lesions in the knee: A narrative review.膝关节软骨下骨髓损伤的疾病分类学和病因学框架:一项叙述性综述。
J Exp Orthop. 2025 Jan 16;12(1):e70071. doi: 10.1002/jeo2.70071. eCollection 2025 Jan.
4
Clinical Characteristics, Current Treatment Options, Potential Mechanisms, Biomarkers, and Therapeutic Targets in Avascular Necrosis of Femoral Head.股骨头缺血性坏死的临床特征、当前治疗选择、潜在机制、生物标志物及治疗靶点
Med Princ Pract. 2024;33(6):519-536. doi: 10.1159/000541044. Epub 2024 Aug 21.
5
Transient osteoporosis of the hip with a femoral neck fracture during follow-up: a case report.随访期间发生股骨颈骨折的髋部暂时性骨质疏松:一例报告
J Yeungnam Med Sci. 2023 Apr;40(2):212-217. doi: 10.12701/jyms.2022.00479. Epub 2022 Sep 26.
6
Osteonecrosis of the Femoral Head in Patients with Hypercoagulability-From Pathophysiology to Therapeutic Implications.高凝状态患者股骨头坏死:从病理生理学到治疗意义。
Int J Mol Sci. 2021 Jun 24;22(13):6801. doi: 10.3390/ijms22136801.
7
Transient Osteoporosis of the Hip: Risk and Therapy.髋部短暂性骨质疏松症:风险与治疗
Open Access Rheumatol. 2020 Jan 9;12:1-8. doi: 10.2147/OARRR.S236324. eCollection 2020.
8
Increased COUP-TFII Expression Mediates the Differentiation Imbalance of Bone Marrow-Derived Mesenchymal Stem Cells in Femoral Head Osteonecrosis.COUP-TFII 表达增加介导了股骨头坏死骨髓间充质干细胞的分化失衡。
Biomed Res Int. 2019 Dec 8;2019:9262430. doi: 10.1155/2019/9262430. eCollection 2019.
9
Long-term direct oral anticoagulation in primary osteonecrosis with elevated plasminogen activation inhibitor.纤溶酶原激活抑制剂升高的原发性骨坏死的长期直接口服抗凝治疗
SAGE Open Med Case Rep. 2019 Feb 4;7:2050313X19827747. doi: 10.1177/2050313X19827747. eCollection 2019.
10
Percutaneous Drilling for Early-Stage Osteonecrosis About the Ankle.经皮钻孔治疗早期踝关节骨坏死
JBJS Essent Surg Tech. 2014 Nov 12;4(4):e21. doi: 10.2106/JBJS.ST.M.00069. eCollection 2014 Dec.